Danilov V V, Vol'nykh I Iu, Danilova T I, Vodop'ianova O A, Kudriakova N A
Urologiia. 2006 Sep-Oct(5):71-4.
The analysis of treatment outcomes in 74 patients with hyperactive urinary bladder (HUB) has shown that duration of the treatment depends on the initial function of the lower urinary tracts. There was a correlation between mean effective therapy and treatment duration. Estimation of this correlation allows prognosis of treatment efficacy and selection of optimal anticholinergic drug for correction of miction disorders. Spasmex proved to be the most adequate drug for long-term treatment due to minimal number of side effects and feasibility to vary dose and regimen of intake.
对74例膀胱过度活动症(HUB)患者治疗结果的分析表明,治疗持续时间取决于下尿路的初始功能。平均有效治疗与治疗持续时间之间存在相关性。对这种相关性的评估有助于预测治疗效果,并为纠正排尿障碍选择最佳抗胆碱能药物。由于副作用最少,且可改变剂量和服用方案,Spasmex被证明是最适合长期治疗的药物。